title: Effectiveness of infliximab in the treatment of refractory perineal cutaneous Crohn disease.
authors.affiliation: Department of Dermatology, Johns Hopkins Medical Institutions, Baltimore, MD 21205, USA.
authors.forename: A S
authors.initials: AS
authors.lastname: Geyer
authors.forename: G J
authors.initials: GJ
authors.lastname: Anhalt
authors.forename: H C
authors.initials: HC
authors.lastname: Nousari
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D003424:Crohn Disease / Q000150:complications*; D003879:Dermatologic Agents / Q000008:administration & dosage*; D005260:Female; D006099:Granuloma / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D000069285:Infliximab; D007275:Injections, Intravenous; D008875:Middle Aged; D010502:Perineum; D012883:Skin Ulcer / Q000188:drug therapy* / Q000209:etiology; D013997:Time Factors
chemical_list: D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D000069285:Infliximab